Form 4 for BNGO Bionano Genomics, Inc.
Accepted 2026-09-09 16:30:06 ET · period of report 2026-09-04 · accession 0001746822-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-09-09 16:30 | 2026-09-04 | BNGO | Luderer Albert | Interim Chief Executive, Dir | P - Purchase | $1.21 | +4,000 | 8,000 | +100% | +$4,845 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-04 | P | A | 4,000 | $1.21 | 8,000 | I Traditional IRA | — | — |